Stereotactic radiosurgery for arteriovenous malformations, Part 6: multistaged volumetric management of large arteriovenous malformations

Clinical article

View More View Less
  • 1 Departments of Neurological Surgery and
  • 2 Radiation Oncology, and
  • 3 Center for Image-Guided Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and
  • 4 Department of Neurosurgery, Taipei Veterans General Hospital, Taipei, Taiwan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

The object of this study was to define the long-term outcomes and risks of arteriovenous malformation (AVM) management using 2 or more stages of stereotactic radiosurgery (SRS) for symptomatic large-volume lesions unsuitable for surgery.

Methods

In 1992, the authors prospectively began to stage the treatment of anatomical components to deliver higher single doses to AVMs with a volume of more than 10 cm3. Forty-seven patients with such AVMs underwent volume-staged SRS. In this series, 18 patients (38%) had a prior hemorrhage and 21 patients (45%) underwent prior embolization. The median interval between the first-stage SRS and the second-stage SRS was 4.9 months (range 2.8–13.8 months). The median target volume was 11.5 cm3 (range 4.0–26 cm3) in the first-stage SRS and 9.5 cm3 in the second-stage SRS. The median margin dose was 16 Gy (range 13–18 Gy) for both stages.

Results

In 17 patients, AVM obliteration was confirmed after 2–4 SRS procedures at a median follow-up of 87 months (range 0.4–209 months). Five patients had near-total obliteration (volume reduction > 75% but residual AVM). The actuarial rates of total obliteration after 2-stage SRS were 7%, 20%, 28%, and 36% at 3, 4, 5, and 10 years, respectively. The 5-year total obliteration rate after the initial staged volumetric SRS with a margin dose of 17 Gy or more was 62% (p = 0.001). Sixteen patients underwent additional SRS at a median interval of 61 months (range 33–113 months) after the initial 2-stage SRS. The overall rates of total obliteration after staged and repeat SRS were 18%, 45%, and 56% at 5, 7, and 10 years, respectively. Ten patients sustained hemorrhage after staged SRS, and 5 of these patients died. Three of 16 patients who underwent repeat SRS sustained hemorrhage after the procedure and died. Based on Kaplan-Meier analysis (excluding the second hemorrhage in the patient who had 2 hemorrhages), the cumulative rates of AVM hemorrhage after SRS were 4.3%, 8.6%, 13.5%, and 36.0% at 1, 2, 5, and 10 years, respectively. This corresponded to annual hemorrhage risks of 4.3%, 2.3%, and 5.6% for Years 0–1, 1–5, and 5–10 after SRS. Multiple hemorrhages before SRS correlated with a significantly higher risk of hemorrhage after SRS. Symptomatic adverse radiation effects were detected in 13% of patients, but no patient died as a result of an adverse radiation effect. Delayed cyst formation did not occur in any patient after SRS.

Conclusions

Prospective volume-staged SRS for large AVMs unsuitable for surgery has potential benefit but often requires more than 2 procedures to complete the obliteration process. To have a reasonable chance of benefit, the minimum margin dose should be 17 Gy or greater, depending on the AVM location. In the future, prospective volume-staged SRS followed by embolization (to reduce flow, obliterate fistulas, and occlude associated aneurysms) may improve obliteration results and further reduce the risk of hemorrhage after SRS.

Abbreviations used in this paper: ARE = adverse radiation effect; AVM = arteriovenous malformation; HR = hazard ratio; SRS = stereotactic radiosurgery.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: L. Dade Lunsford, M.D., Department of Neurological Surgery, University of Pittsburgh, Suite B-400, UPMC Presbyterian, 200 Lothrop Street, Pittsburgh, Pennsylvania 15213. email: lunsfordld@upmc.edu.

Please include this information when citing this paper: published online November 11, 2011; DOI: 10.3171/2011.9.JNS11177.

  • 1

    Chung WY, , Shiau CY, , Wu HM, , Liu KD, , Guo WY, & Wang LW, : Staged radiosurgery for extra-large cerebral arteriovenous malformations: method, implementation, and results. J Neurosurg 109:Suppl 6572, 2008

    • Search Google Scholar
    • Export Citation
  • 2

    Colombo F, , Pozza F, , Chierego G, , Casentini L, , De Luca G, & Francescon P: Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery 34:1421, 1994

    • Search Google Scholar
    • Export Citation
  • 3

    Dawson RC III, , Tarr RW, , Hecht ST, , Jungreis CA, , Lunsford LD, & Coffey R, : Treatment of arteriovenous malformations of the brain with combined embolization and stereotactic radiosurgery: results after 1 and 2 years. AJNR Am J Neuroradiol 11:857864, 1990

    • Search Google Scholar
    • Export Citation
  • 4

    Firlik AD, , Levy EI, , Kondziolka D, & Yonas H: Staged volume radiosurgery followed by microsurgical resection: a novel treatment for giant cerebral arteriovenous malformations: technical case report. Neurosurgery 43:12231228, 1998

    • Search Google Scholar
    • Export Citation
  • 5

    Flickinger JC, , Kondziolka D, , Lunsford LD, , Kassam A, , Phuong LK, & Liscak R, : Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys 46:11431148, 2000

    • Search Google Scholar
    • Export Citation
  • 6

    Flickinger JC, , Pollock BE, , Kondziolka D, & Lunsford LD: A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 36:873879, 1996

    • Search Google Scholar
    • Export Citation
  • 7

    Friedlander RM: Clinical practice. Arteriovenous malformations of the brain. N Engl J Med 356:27042712, 2007

  • 8

    Gobin YP, , Laurent A, , Merienne L, , Schlienger M, , Aymard A, & Houdart E, : Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 85:1928, 1996

    • Search Google Scholar
    • Export Citation
  • 9

    Inoue HK, & Ohye C: Hemorrhage risks and obliteration rates of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg 97:5 Suppl 474476, 2002

    • Search Google Scholar
    • Export Citation
  • 10

    Liscák R, , Vladyka V, , Simonová G, , Urgosík D, , Novotný J Jr, & Janousková L, : Arteriovenous malformations after Leksell gamma knife radiosurgery: rate of obliteration and complications. Neurosurgery 60:10051016, 2007

    • Search Google Scholar
    • Export Citation
  • 11

    Lunsford LD, , Kondziolka D, , Flickinger JC, , Bissonette DJ, , Jungreis CA, & Maitz AH, : Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 75:512524, 1991

    • Search Google Scholar
    • Export Citation
  • 12

    Ogilvy CS, , Stieg PE, , Awad I, , Brown RD Jr, , Kondziolka D, & Rosenwasser R, : AHA Scientific Statement. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 103:26442657, 2001

    • Search Google Scholar
    • Export Citation
  • 13

    Pan DH, , Guo WY, , Chung WY, , Shiau CY, , Chang YC, & Wang LW: Gamma knife radiosurgery as a single treatment modality for large cerebral arteriovenous malformations. J Neurosurg 93:Suppl 3 113119, 2000

    • Search Google Scholar
    • Export Citation
  • 14

    Paulsen RD, , Steinberg GK, , Norbash AM, , Marcellus ML, & Marks MP: Embolization of basal ganglia and thalamic arteriovenous malformations. Neurosurgery 44:991997, 1999

    • Search Google Scholar
    • Export Citation
  • 15

    Pollock BE, & Flickinger JC: A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg 96:7985, 2002

  • 16

    Pollock BE, , Flickinger JC, , Lunsford LD, , Maitz A, & Kondziolka D: Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery 42:12391247, 1998

    • Search Google Scholar
    • Export Citation
  • 17

    Pollock BE, , Kline RW, , Stafford SL, , Foote RL, & Schomberg PJ: The rationale and technique of staged-volume arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 48:817824, 2000

    • Search Google Scholar
    • Export Citation
  • 18

    Pollock BE, , Kondziolka D, , Flickinger JC, , Patel AK, , Bissonette DJ, & Lunsford LD: Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg 85:10441049, 1996

    • Search Google Scholar
    • Export Citation
  • 19

    Pollock BE, & Meyer FB: Radiosurgery for arteriovenous malformations. J Neurosurg 101:390392, 2004

  • 20

    Redekop GJ, , Elisevich KV, , Gaspar LE, , Wiese KP, & Drake CG: Conventional radiation therapy of intracranial arteriovenous malformations: long-term results. J Neurosurg 78:413422, 1993

    • Search Google Scholar
    • Export Citation
  • 21

    Seifert V, , Stolke D, , Mehdorn HM, & Hoffmann B: Clinical and radiological evaluation of long-term results of stereotactic proton beam radiosurgery in patients with cerebral arteriovenous malformations. J Neurosurg 81:683689, 1994

    • Search Google Scholar
    • Export Citation
  • 22

    Sinclair J, , Kelly ME, & Steinberg GK: Surgical management of posterior fossa arteriovenous malformations. Neurosurgery 58:4 Suppl 2 ONS-189ONS-201, 2006

    • Search Google Scholar
    • Export Citation
  • 23

    Sirin S, , Kondziolka D, , Niranjan A, , Flickinger JC, , Maitz AH, & Lunsford LD: Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients. Neurosurgery 58:1727, 2006

    • Search Google Scholar
    • Export Citation
  • 24

    Spetzler RF, & Martin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 65:476483, 1986

  • 25

    Weber W, , Kis B, , Siekmann R, & Kuehne D: Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 28:371377, 2007

    • Search Google Scholar
    • Export Citation
  • 26

    Wegner RE, , Oysul K, , Pollock BE, , Sirin S, , Kondziolka D, & Niranjan A, : A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys 79:11471150, 2011

    • Search Google Scholar
    • Export Citation
  • 27

    Yamamoto Y, , Coffey RJ, , Nichols DA, & Shaw EG: Interim report on the radiosurgical treatment of cerebral arteriovenous malformations. The influence of size, dose, time, and technical factors on obliteration rate. J Neurosurg 83:832837, 1995

    • Search Google Scholar
    • Export Citation
  • 28

    Yang SY, , Kim DG, , Chung HT, , Paek SH, , Park JH, & Han DH: Radiosurgery for large cerebral arteriovenous malformations. Acta Neurochir (Wien) 151:113124, 2009

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 585 205 15
Full Text Views 319 39 1
PDF Downloads 193 31 0
EPUB Downloads 0 0 0